[Federal Register Volume 66, Number 123 (Tuesday, June 26, 2001)]
[Notices]
[Page 33985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15979]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (Texas Biotechnology Corporation, Common Stock, $.005 
Par Value, Per Share) File No. 1-12574

June 20, 2001.
    Texas Biotechnology Corporation, a Delaware corporation 
(``Company''), has filed an application with the Securities and 
Exchange Commission (``Commission''), pursuant to section 12(d) of the 
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 12d2-2(d) 
thereunder,\2\ to withdraw its Common Stock, $.005 par value 
(``Security''), from listing and registration on the American Stock 
Exchange (``Amex'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Company represents that trading in the Security began on the 
Nasdaq National Market, and ceased concurrently on the Amex, at the 
opening of business on June 19, 2001. In making the decision to 
withdraw the Security from listing on the Exchange, the Company 
considered the liquidity to be provided by its inclusion on the Nasdaq 
National Market and the cost of maintaining the Amex listing.
    The Company stated in its application that it has met the 
requirements of Amex Rule 18 by complying with all applicable laws in 
effect in the State of Delaware, in which it is incorporated, and with 
the Amex's rules governing an issuer's voluntary withdrawal of a 
security from listing and registration. The Company's application 
relates solely to the Security's withdrawal from l listing on the Amex 
and shall affect neither its approval for listing on the Nasdaq 
National Market nor its obligation to be registered under section 12(g) 
of the Act.\3\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    Any interested person may, on or before July 10, 2001, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the Amex and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\4\

    \4\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 01-15979 Filed 6-25-01; 8:45 am]
BILLING CODE 8010-01-M